In his weekly clinical update, Dr. Griffin discusses the CDC HIV surveillance report, FDA voted in favor of approving the Abrysvo vaccine, canine olfactory detection of SARS-CoV-2-infected humans, safety of the BNT162b2 COVID-19 vaccine in children aged 5 to 17 years, and statement on the antigen composition of COVID-19 vaccines.
Click arrow to play
Download TWiV 1010 (21 MB .mp3, 36 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- HIV surveillance report (CDC) 1:44
- FDA voted in favor of approving Abrysvo vaccine (Pfizer) 11:05
- Canine olfactory detection of SARS-CoV-2-infected humans (Annals of Epidemiology) 13:48
- Safety of the BNT162b2 COVID-19 vaccine in children (JAMA) 16:05
- Statement on the antigen composition of COVID-19 vaccines (WHO) 18:10
- Contribute to our FIMRC fundraiser at PWB 26:32
- Letters read on TWiV 1010 26:56
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
Leave a Reply